Industry Research Reports

Home > Reports > Chemical & Material > Retigabine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Retigabine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Chemical & Material

Published Date: 2024-02-19

Pages: 133 Pages

Report ld: 2526523

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Retigabine is a highly pure, synthetic, and biologically active compound.

The global market for Retigabine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Retigabine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Retigabine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Retigabine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Retigabine include Merck, BioVision, Selleck Chemicals, Bio-Techne, Cayman Chemical, Adooq Bioscience, Alomone Labs, Toronto Research Chemicals and BOCSCI, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

MARKET SEGMENTATION

By Company

Merck
BioVision
Selleck Chemicals
Bio-Techne
Cayman Chemical
Adooq Bioscience
Alomone Labs
Toronto Research Chemicals
BOCSCI
Biosynth Carbosynth
Axon Biochemicals BV
Beyotime

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%

Segment by Application

Research
Medical

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Retigabine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Retigabine by region & country, by Type, and by Application.

The Retigabine market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Retigabine.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Retigabine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Retigabine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Retigabine in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Retigabine Product Introduction

1.2 Global Retigabine Market Size Forecast

1.2.1 Global Retigabine Sales Value (2019-2030)

1.2.2 Global Retigabine Sales Volume (2019-2030)

1.2.3 Global Retigabine Sales Price (2019-2030)

1.3 Retigabine Market Trends & Drivers

1.3.1 Retigabine Industry Trends

1.3.2 Retigabine Market Drivers & Opportunity

1.3.3 Retigabine Market Challenges

1.3.4 Retigabine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Retigabine Players Revenue Ranking (2023)

2.2 Global Retigabine Revenue by Company (2019-2024)

2.3 Global Retigabine Players Sales Volume Ranking (2023)

2.4 Global Retigabine Sales Volume by Company Players (2019-2024)

2.5 Global Retigabine Average Price by Company (2019-2024)

2.6 Key Manufacturers Retigabine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Retigabine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Retigabine

2.9 Retigabine Market Competitive Analysis

2.9.1 Retigabine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Retigabine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retigabine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Min Purity Less Than 98%

3.1.2 Min Purity 98%-99%

3.1.3 Min Purity More Than 99%

3.2 Global Retigabine Sales Value by Type

3.2.1 Global Retigabine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Retigabine Sales Value, by Type (2019-2030)

3.2.3 Global Retigabine Sales Value, by Type (%) (2019-2030)

3.3 Global Retigabine Sales Volume by Type

3.3.1 Global Retigabine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Retigabine Sales Volume, by Type (2019-2030)

3.3.3 Global Retigabine Sales Volume, by Type (%) (2019-2030)

3.4 Global Retigabine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Research

4.1.2 Medical

4.2 Global Retigabine Sales Value by Application

4.2.1 Global Retigabine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Retigabine Sales Value, by Application (2019-2030)

4.2.3 Global Retigabine Sales Value, by Application (%) (2019-2030)

4.3 Global Retigabine Sales Volume by Application

4.3.1 Global Retigabine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Retigabine Sales Volume, by Application (2019-2030)

4.3.3 Global Retigabine Sales Volume, by Application (%) (2019-2030)

4.4 Global Retigabine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Retigabine Sales Value by Region

5.1.1 Global Retigabine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Retigabine Sales Value by Region (2019-2024)

5.1.3 Global Retigabine Sales Value by Region (2025-2030)

5.1.4 Global Retigabine Sales Value by Region (%), (2019-2030)

5.2 Global Retigabine Sales Volume by Region

5.2.1 Global Retigabine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Retigabine Sales Volume by Region (2019-2024)

5.2.3 Global Retigabine Sales Volume by Region (2025-2030)

5.2.4 Global Retigabine Sales Volume by Region (%), (2019-2030)

5.3 Global Retigabine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Retigabine Sales Value, 2019-2030

5.4.2 North America Retigabine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Retigabine Sales Value, 2019-2030

5.5.2 Europe Retigabine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Retigabine Sales Value, 2019-2030

5.6.2 Asia Pacific Retigabine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Retigabine Sales Value, 2019-2030

5.7.2 South America Retigabine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Retigabine Sales Value, 2019-2030

5.8.2 Middle East & Africa Retigabine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Retigabine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Retigabine Sales Value

6.2.1 Key Countries/Regions Retigabine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Retigabine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Retigabine Sales Value, 2019-2030

6.3.2 United States Retigabine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Retigabine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Retigabine Sales Value, 2019-2030

6.4.2 Europe Retigabine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Retigabine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Retigabine Sales Value, 2019-2030

6.5.2 China Retigabine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Retigabine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Retigabine Sales Value, 2019-2030

6.6.2 Japan Retigabine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Retigabine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Retigabine Sales Value, 2019-2030

6.7.2 South Korea Retigabine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Retigabine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Retigabine Sales Value, 2019-2030

6.8.2 Southeast Asia Retigabine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Retigabine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Retigabine Sales Value, 2019-2030

6.9.2 India Retigabine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Retigabine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Merck

7.1.1 Merck Company Information

7.1.2 Merck Introduction and Business Overview

7.1.3 Merck Retigabine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Merck Retigabine Product Offerings

7.1.5 Merck Recent Development

7.2 BioVision

7.2.1 BioVision Company Information

7.2.2 BioVision Introduction and Business Overview

7.2.3 BioVision Retigabine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 BioVision Retigabine Product Offerings

7.2.5 BioVision Recent Development

7.3 Selleck Chemicals

7.3.1 Selleck Chemicals Company Information

7.3.2 Selleck Chemicals Introduction and Business Overview

7.3.3 Selleck Chemicals Retigabine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Selleck Chemicals Retigabine Product Offerings

7.3.5 Selleck Chemicals Recent Development

7.4 Bio-Techne

7.4.1 Bio-Techne Company Information

7.4.2 Bio-Techne Introduction and Business Overview

7.4.3 Bio-Techne Retigabine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Bio-Techne Retigabine Product Offerings

7.4.5 Bio-Techne Recent Development

7.5 Cayman Chemical

7.5.1 Cayman Chemical Company Information

7.5.2 Cayman Chemical Introduction and Business Overview

7.5.3 Cayman Chemical Retigabine Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Cayman Chemical Retigabine Product Offerings

7.5.5 Cayman Chemical Recent Development

7.6 Adooq Bioscience

7.6.1 Adooq Bioscience Company Information

7.6.2 Adooq Bioscience Introduction and Business Overview

7.6.3 Adooq Bioscience Retigabine Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Adooq Bioscience Retigabine Product Offerings

7.6.5 Adooq Bioscience Recent Development

7.7 Alomone Labs

7.7.1 Alomone Labs Company Information

7.7.2 Alomone Labs Introduction and Business Overview

7.7.3 Alomone Labs Retigabine Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Alomone Labs Retigabine Product Offerings

7.7.5 Alomone Labs Recent Development

7.8 Toronto Research Chemicals

7.8.1 Toronto Research Chemicals Company Information

7.8.2 Toronto Research Chemicals Introduction and Business Overview

7.8.3 Toronto Research Chemicals Retigabine Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Toronto Research Chemicals Retigabine Product Offerings

7.8.5 Toronto Research Chemicals Recent Development

7.9 BOCSCI

7.9.1 BOCSCI Company Information

7.9.2 BOCSCI Introduction and Business Overview

7.9.3 BOCSCI Retigabine Sales, Revenue and Gross Margin (2019-2024)

7.9.4 BOCSCI Retigabine Product Offerings

7.9.5 BOCSCI Recent Development

7.10 Biosynth Carbosynth

7.10.1 Biosynth Carbosynth Company Information

7.10.2 Biosynth Carbosynth Introduction and Business Overview

7.10.3 Biosynth Carbosynth Retigabine Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Biosynth Carbosynth Retigabine Product Offerings

7.10.5 Biosynth Carbosynth Recent Development

7.11 Axon Biochemicals BV

7.11.1 Axon Biochemicals BV Company Information

7.11.2 Axon Biochemicals BV Introduction and Business Overview

7.11.3 Axon Biochemicals BV Retigabine Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Axon Biochemicals BV Retigabine Product Offerings

7.11.5 Axon Biochemicals BV Recent Development

7.12 Beyotime

7.12.1 Beyotime Company Information

7.12.2 Beyotime Introduction and Business Overview

7.12.3 Beyotime Retigabine Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Beyotime Retigabine Product Offerings

7.12.5 Beyotime Recent Development

8 Industry Chain Analysis

8.1 Retigabine Industrial Chain

8.2 Retigabine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Retigabine Sales Model

8.5.2 Sales Channel

8.5.3 Retigabine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Retigabine Market Trends

Table 2. Retigabine Market Drivers & Opportunity

Table 3. Retigabine Market Challenges

Table 4. Retigabine Market Restraints

Table 5. Global Retigabine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Retigabine Revenue Market Share by Company (2019-2024)

Table 7. Global Retigabine Sales Volume by Company (2019-2024) & (Kg)

Table 8. Global Retigabine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Retigabine Price by Company (2019-2024) & (K USD/Kg)

Table 10. Key Manufacturers Retigabine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Retigabine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Retigabine

Table 13. Global Retigabine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retigabine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Retigabine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Retigabine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Retigabine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Retigabine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Retigabine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Retigabine Sales Volume by Type: 2019 VS 2023 VS 2030 (Kg)

Table 22. Global Retigabine Sales Volume by Type (2019-2024) & (Kg)

Table 23. Global Retigabine Sales Volume by Type (2025-2030) & (Kg)

Table 24. Global Retigabine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Retigabine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Retigabine Price by Type (2019-2024) & (K USD/Kg)

Table 27. Global Retigabine Price by Type (2025-2030) & (K USD/Kg)

Table 28. Global Retigabine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Retigabine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Retigabine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Retigabine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Retigabine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Retigabine Sales Volume by Application: 2019 VS 2023 VS 2030 (Kg)

Table 34. Global Retigabine Sales Volume by Application (2019-2024) & (Kg)

Table 35. Global Retigabine Sales Volume by Application (2025-2030) & (Kg)

Table 36. Global Retigabine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Retigabine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Retigabine Price by Application (2019-2024) & (K USD/Kg)

Table 39. Global Retigabine Price by Application (2025-2030) & (K USD/Kg)

Table 40. Global Retigabine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Retigabine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Retigabine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Retigabine Sales Value by Region (2019-2024) & (%)

Table 44. Global Retigabine Sales Value by Region (2025-2030) & (%)

Table 45. Global Retigabine Sales Volume by Region (Kg): 2019 VS 2023 VS 2030

Table 46. Global Retigabine Sales Volume by Region (2019-2024) & (Kg)

Table 47. Global Retigabine Sales Volume by Region (2025-2030) & (Kg)

Table 48. Global Retigabine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Retigabine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Retigabine Average Price by Region (2019-2024) & (K USD/Kg)

Table 51. Global Retigabine Average Price by Region (2025-2030) & (K USD/Kg)

Table 52. Key Countries/Regions Retigabine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Retigabine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Retigabine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Retigabine Sales Volume, (2019-2024) & (Kg)

Table 56. Key Countries/Regions Retigabine Sales Volume, (2025-2030) & (Kg)

Table 57. Merck Company Information

Table 58. Merck Introduction and Business Overview

Table 59. Merck Retigabine Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 60. Merck Retigabine Product Offerings

Table 61. Merck Recent Development

Table 62. BioVision Company Information

Table 63. BioVision Introduction and Business Overview

Table 64. BioVision Retigabine Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 65. BioVision Retigabine Product Offerings

Table 66. BioVision Recent Development

Table 67. Selleck Chemicals Company Information

Table 68. Selleck Chemicals Introduction and Business Overview

Table 69. Selleck Chemicals Retigabine Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 70. Selleck Chemicals Retigabine Product Offerings

Table 71. Selleck Chemicals Recent Development

Table 72. Bio-Techne Company Information

Table 73. Bio-Techne Introduction and Business Overview

Table 74. Bio-Techne Retigabine Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 75. Bio-Techne Retigabine Product Offerings

Table 76. Bio-Techne Recent Development

Table 77. Cayman Chemical Company Information

Table 78. Cayman Chemical Introduction and Business Overview

Table 79. Cayman Chemical Retigabine Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 80. Cayman Chemical Retigabine Product Offerings

Table 81. Cayman Chemical Recent Development

Table 82. Adooq Bioscience Company Information

Table 83. Adooq Bioscience Introduction and Business Overview

Table 84. Adooq Bioscience Retigabine Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 85. Adooq Bioscience Retigabine Product Offerings

Table 86. Adooq Bioscience Recent Development

Table 87. Alomone Labs Company Information

Table 88. Alomone Labs Introduction and Business Overview

Table 89. Alomone Labs Retigabine Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 90. Alomone Labs Retigabine Product Offerings

Table 91. Alomone Labs Recent Development

Table 92. Toronto Research Chemicals Company Information

Table 93. Toronto Research Chemicals Introduction and Business Overview

Table 94. Toronto Research Chemicals Retigabine Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 95. Toronto Research Chemicals Retigabine Product Offerings

Table 96. Toronto Research Chemicals Recent Development

Table 97. BOCSCI Company Information

Table 98. BOCSCI Introduction and Business Overview

Table 99. BOCSCI Retigabine Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 100. BOCSCI Retigabine Product Offerings

Table 101. BOCSCI Recent Development

Table 102. Biosynth Carbosynth Company Information

Table 103. Biosynth Carbosynth Introduction and Business Overview

Table 104. Biosynth Carbosynth Retigabine Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 105. Biosynth Carbosynth Retigabine Product Offerings

Table 106. Biosynth Carbosynth Recent Development

Table 107. Axon Biochemicals BV Company Information

Table 108. Axon Biochemicals BV Introduction and Business Overview

Table 109. Axon Biochemicals BV Retigabine Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 110. Axon Biochemicals BV Retigabine Product Offerings

Table 111. Axon Biochemicals BV Recent Development

Table 112. Beyotime Company Information

Table 113. Beyotime Introduction and Business Overview

Table 114. Beyotime Retigabine Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 115. Beyotime Retigabine Product Offerings

Table 116. Beyotime Recent Development

Table 117. Key Raw Materials Lists

Table 118. Raw Materials Key Suppliers Lists

Table 119. Retigabine Downstream Customers

Table 120. Retigabine Distributors List

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Retigabine Product Picture

Figure 2. Global Retigabine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Retigabine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Retigabine Sales Volume (2019-2030) & (Kg)

Figure 5. Global Retigabine Sales Price (2019-2030) & (K USD/Kg)

Figure 6. Retigabine Report Years Considered

Figure 7. Global Retigabine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Retigabine Players Sales Volume Ranking (2023) & (Kg)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Retigabine Revenue in 2023

Figure 10. Retigabine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Min Purity Less Than 98% Picture

Figure 12. Min Purity 98%-99% Picture

Figure 13. Min Purity More Than 99% Picture

Figure 14. Global Retigabine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 15. Global Retigabine Sales Value Market Share by Type, 2023 & 2030

Figure 16. Global Retigabine Sales Volume by Type (2019 VS 2023 VS 2030) & (Kg)

Figure 17. Global Retigabine Sales Volume Market Share by Type, 2023 & 2030

Figure 18. Global Retigabine Price by Type (2019-2030) & (K USD/Kg)

Figure 19. Product Picture of Research

Figure 20. Product Picture of Medical

Figure 21. Global Retigabine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Retigabine Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Retigabine Sales Volume by Application (2019 VS 2023 VS 2030) & (Kg)

Figure 24. Global Retigabine Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Retigabine Price by Application (2019-2030) & (K USD/Kg)

Figure 26. North America Retigabine Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Retigabine Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Retigabine Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Retigabine Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Retigabine Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Retigabine Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Retigabine Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Retigabine Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Retigabine Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Retigabine Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Retigabine Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Retigabine Sales Volume (%), (2019-2030)

Figure 38. United States Retigabine Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Retigabine Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Retigabine Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Retigabine Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Retigabine Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Retigabine Sales Value by Application (%), 2023 VS 2030

Figure 44. China Retigabine Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Retigabine Sales Value by Type (%), 2023 VS 2030

Figure 46. China Retigabine Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Retigabine Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Retigabine Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Retigabine Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Retigabine Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Retigabine Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Retigabine Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Retigabine Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Retigabine Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Retigabine Sales Value by Application (%), 2023 VS 2030

Figure 56. India Retigabine Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Retigabine Sales Value by Type (%), 2023 VS 2030

Figure 58. India Retigabine Sales Value by Application (%), 2023 VS 2030

Figure 59. Retigabine Industrial Chain

Figure 60. Retigabine Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Retigabine market? zhanKai

The top companies in the global Retigabine market are Merck、BioVision、Selleck Chemicals.

Related Reports

Retigabine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Retigabine was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 141
USD 3950.00
(Single User License)
Global Retigabine Market Research Report 2026
The global Retigabine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 143
USD 2900.00
(Single User License)
Global Retigabine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Retigabine market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 163
USD 4900.00
(Single User License)
Retigabine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Retigabine was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 122
USD 3950.00
(Single User License)
Global Retigabine Market Research Report 2025
The global market for Retigabine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 98
USD 2900.00
(Single User License)
Global Retigabine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Retigabine market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 100
USD 4250.00
(Single User License)
Global Retigabine Market Insights, Forecast to 2030
Retigabine is a highly pure, synthetic, and biologically active compound.
Published Date: 2024-04-07
Pages: 111
USD 4900.00
(Single User License)
Global Retigabine Market Research Report 2024
Retigabine is a highly pure, synthetic, and biologically active compound.
Published Date: 2024-01-12
Pages: 98
USD 2900.00
(Single User License)

Retigabine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Retigabine was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 141
USD 3950.00 (Single User License)
Global Retigabine Market Research Report 2026
The global Retigabine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 143
USD 2900.00 (Single User License)
Global Retigabine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Retigabine market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 163
USD 4900.00 (Single User License)
Retigabine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Retigabine was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 122
USD 3950.00 (Single User License)
Global Retigabine Market Research Report 2025
The global market for Retigabine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 98
USD 2900.00 (Single User License)
Global Retigabine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Retigabine market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 100
USD 4250.00 (Single User License)
Global Retigabine Market Insights, Forecast to 2030
Retigabine is a highly pure, synthetic, and biologically active compound.
Published: 2024-04-07
Pages: 111
USD 4900.00 (Single User License)
Global Retigabine Market Research Report 2024
Retigabine is a highly pure, synthetic, and biologically active compound.
Published: 2024-01-12
Pages: 98
USD 2900.00 (Single User License)